Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
PUT
MPLX
MPLX
$60.2B
| $527K | ﹤0.01% |
18,800
-200,200
| -91% | -$5.87M |
|
|
SP
4127
DELISTED
SP Plus Corporation
SP
| $527K | ﹤0.01% |
14,250
-3,095
| -18% | -$108K |
|
4128
Atara Biotherapeutics
ATRA
$76.9M
| $526K | ﹤0.01% |
1,491
-1,976
| -57% | -$737K |
|
4129
CALL
FMC
FMC
$1.35B
| $526K | ﹤0.01% |
6,000
-1,200
| -17% | -$103K |
|
4130
PUT
NIO
NIO
$11.7B
| $526K | ﹤0.01% |
337,000
+317,000
| +1,585% | +$970K |
|
|
CHL
4131
PUT
DELISTED
China Mobile Limited
CHL
| $526K | ﹤0.01% |
12,700
+5,300
| +72% | +$226K |
|
4132
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$64.7M
| $525K | ﹤0.01% |
4,400
+3,300
| +300% | +$394K |
|
|
SPWR
4133
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $524K | ﹤0.01% |
72,991
+43,673
| +149% | +$360K |
|
4134
Cato Corp
CATO
$68.5M
| $523K | ﹤0.01% |
29,677
+3,552
| +14% | +$53.3K |
|
4135
Cheniere Energy
CQP
$31B
| $523K | ﹤0.01% |
11,473
-13,460
| -54% | -$598K |
|
|
HSII
4136
DELISTED
Heidrick & Struggles
HSII
| $523K | ﹤0.01% |
19,198
-10,667
| -36% | -$300K |
|
|
SIEN
4137
PUT
DELISTED
Sientra, Inc.
SIEN
| $523K | ﹤0.01% |
8,070
+6,870
| +573% | +$437K |
|
|
LDL
4138
DELISTED
Lydall, Inc.
LDL
| $522K | ﹤0.01% |
20,953
+943
| +5% | +$20.1K |
|
4139
CALL
Brunswick
BC
$5.43B
| $521K | ﹤0.01% |
+10,000
| New | +$477K |
|
|
NS
4140
DELISTED
NuStar Energy L.P.
NS
| $521K | ﹤0.01% |
18,374
-16,333
| -47% | -$455K |
|
4141
PUT
Designer Brands
DBI
$339M
| $520K | ﹤0.01% |
30,400
+7,700
| +34% | +$131K |
|
4142
ING
ING
$103B
| $519K | ﹤0.01% |
49,606
+49,172
| +11,330% | +$517K |
|
4143
CALL
Norwegian Cruise Line
NCLH
$9.32B
| $518K | ﹤0.01% |
10,000
+5,100
| +104% | +$259K |
|
4144
PUT
BorgWarner
BWA
$13.7B
| $517K | ﹤0.01% |
16,018
+7,271
| +83% | +$234K |
|
|
BAND
4145
Bandwidth Inc
BAND
$1.47B
| $516K | ﹤0.01% |
7,926
-4,445
| -36% | -$347K |
|
4146
CALL
Western Midstream Partners
WES
$19.1B
| $515K | ﹤0.01% |
20,700
-38,200
| -65% | -$1.02M |
|
4147
Middlesex Water
MSEX
$1.08B
| $514K | ﹤0.01% |
7,906
-2,440
| -24% | -$149K |
|
|
SABA
4148
Saba Capital Income & Opportunities Fund II
SABA
$224M
| $514K | ﹤0.01% |
41,834
-14,500
| -26% | -$182K |
|
4149
Wyndham Hotels & Resorts
WH
$5.65B
| $514K | ﹤0.01% |
9,948
-52,600
| -84% | -$2.88M |
|
4150
PUT
ResMed
RMD
$32.5B
| $513K | ﹤0.01% |
3,800
-700
| -16% | -$91.7K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.